Caribou Biosciences, Inc.
CRBU- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001619856
No open-market purchases or sales by Caribou Biosciences, Inc. insiders were filed in the last 90 days; 137 institutions reported holding it in 13F filings for Q2 2026, worth $84.8M in total; Maverick Capital is the only superinvestor holding it.
Q4 2023 vs. Q3 2023
How the institutions holding Caribou Biosciences, Inc. changed between Q3 2023 and Q4 2023.
All holders in Q4 2023All holders in Q3 2023
| Measure | Q3 2023 | Q4 2023 | Change |
|---|---|---|---|
| Holders | 126 | 144 | +18 |
| Shares | 70.8M | 69.1M | −1.70M (−2.4%) |
| Value | $338.5M | $395.8M | +$57.3M (+16.9%) |
New holders (30)
Institutions that held Caribou Biosciences, Inc. at the end of Q4 2023 but not at the end of Q3 2023.
Sold out (12)
Institutions that held Caribou Biosciences, Inc. at the end of Q3 2023 and filed for Q4 2023 without it.
| Institution | Shares, Q3 2023 | Value, Q3 2023 |
|---|---|---|
| Deerfield Management Company, L.P. (Series C) | 3,500,000 | $16.7M |
| Walleye Capital LLC | 468,127 | $2.24M |
| Jump Financial, LLC | 92,204 | $440.7K |
| Long Focus Capital Management, LLC | 65,000 | $310.7K |
| Walleye Trading LLC | 35,899 | $171.6K |
| SVB Financial Group | 20,714 | $99.0K |
| Penserra Capital Management LLC | 18,672 | $89.0K |
| Belvedere Trading LLC | 17,429 | $83.3K |
| Mutual Advisors, LLC | 17,366 | $83.0K |
| Gsa Capital Partners LLP | 10,734 | $51.0K |
| Citadel Advisors LLC | 2,989 | $14.3K |
| Group One Trading, L.P. | 745 | $3.56K |